Abecassis Michael M bought PMCB
March 31, 2026 · Form 4 insider transaction
Abecassis Michael M bought 119,170 shares of PharmaCyte Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
119,170
Price
$0.00
Total value
N/A
InsiderAbecassis Michael M
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 31, 2026
Filing dateApril 2, 2026
Shares owned after119,170
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis.